CVDevices, LLC
6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
56
Ending by 2030
Feb 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Dec 9, 2026
- 2 fees due Jan 28 to 30, 2027 · next Jan 28
- 4 fees due Feb 1 to 27, 2027 · next Feb 1
- 2 fees due Apr 8 to 22, 2027 · next Apr 8
- 3 fees due Jun 1 to 10, 2027 · next Jun 1
- 1 fee due Jul 28, 2027The maintenance fee for Systems and methods for cryoablation of a tissue (US 10,543,033) comes due Jul 28, 2027. Unpaid by Jan 28, 2028, it lapses early.
- 1 fee due Aug 11, 2027The maintenance fee for Devices, systems, and methods for valve removal (US 10,555,767) comes due Aug 11, 2027. Unpaid by Feb 11, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,285,814 | Devices and methods for controlling blood perfusion pressure In force · From the USPTO record | In force | From the USPTO record | |
| US 8,075,532 | Devices, systems, and methods for pericardial access In force · From the USPTO record | In force | From the USPTO record | |
| US 8,540,674 | Devices, systems, and methods for transeptal atrial puncture using an engagement catheter platform In force · From the USPTO record | In force | From the USPTO record | |
| US 8,777,904 | Systems and methods for engaging heart tissue In force · From the USPTO record | In force | From the USPTO record | |
| US 8,882,765 | Devices, systems, and methods for epicardial navigation In force · From the USPTO record | In force | From the USPTO record | |
| US 10,213,207 | Septal Occlusion Devices and Methods In force · Low confidence | In force | Low confidence | |
| US 8,876,776 | Engagement catheter systems and devices and methods of using the same In force · From the USPTO record | In force | From the USPTO record | |
| US 11,191,955 | Devices and systems for accessing cardiac tissue In force · From the USPTO record | In force | From the USPTO record | |
| US 11,771,558 | Devices and methods for controlling blood perfusion pressure along with regional mild hypothermia In force · From the USPTO record | In force | From the USPTO record | |
| US 8,894,606 | Devices, systems, and methods for accessing cardiac tissue In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 81: 6 patents in force now held by others · 27 lapsed for an unpaid fee · 5 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 1 abandoned · 28 no status recorded